Page 5 of 9 – SEC Filing
| Item 1(a). | NAME OF ISSUER: |
| The name of the issuer is EyeGate Pharmaceuticals, Inc. (the “Company“). | |
| Item 1(b). | ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES: |
| The Company’s principal executive offices are located at 271 Waverley Oaks Road, Suite 108, Waltham, MA 02452. | |
| Item 2(a). | NAME OF PERSON FILING: |
| This statement is filed by the entities and persons listed below, who are collectively referred to herein as “Reporting Persons,” with respect to the shares of Common Stock (as defined in Item 2(d) below) of the Company: | |
| Investment Manager | |
| (i) Empery Asset Management, LP (the “Investment Manager“), with respect to the shares of Common Stock held by, and underlying the Reported Warrants (as defined below) held by, the funds to which the Investment Manager serves as investment manager (the “Empery Funds“ | |
| Reporting Individuals | |
| (ii) Mr. Ryan M. Lane (“Mr. Lane“), with respect to the shares of Common Stock held by, and underlying the Reported Warrants held by, the Empery Funds. | |
| (iii) Mr. Martin D. Hoe (“Mr. Hoe“), with respect to the shares of Common Stock held by, and underlying the Reported Warrants held by, the Empery Funds | |
| The Investment Manager serves as the investment manager to each of the Empery Funds. Each of the Mr. Lane and Mr. Hoe (the “Reporting Individuals“) is a Managing Member of Empery AM GP, LLC (the “General Partner“), the general partner of the Investment Manager. |
| Item 2(b). | ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: |
| The address of the business office of each of the Reporting Persons 1 Rockefeller Plaza, Suite 1205 New York, New York 10020 |
| Item 2(c). | CITIZENSHIP: |
| Citizenship is set forth in Row 4 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. |
| Item 2(d). | TITLE OF CLASS OF SECURITIES: |
| Common Stock, $0.01 par value (the “Common Stock“) |
| Item 2(e). | CUSIP NUMBER: |
| 30233M107 |
Follow Kiora Pharmaceuticals Inc (NASDAQ:KPRX)
Follow Kiora Pharmaceuticals Inc (NASDAQ:KPRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
